Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1624, 2008-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Efalizumab: durable benefits in plaque psoriasis
Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. :
Access to resources
Recommend
Etanercept, efalizumab repair QOL in chronic plaque psoriasis
Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. :
Efalizumab: high response rates in plaque psoriasis
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :
Etanercept, efalizumab repair QOL in chronic plaque psoriasis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 463, 2004-01 ,pp. :
Alefacept an effective treatment for plaque psoriasis
Inpharma, Vol. 1, Iss. 1299, 2001-01 ,pp. :